Standout Papers

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes 2005 2026 2012 2019 3.5k
  1. Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes (2005)
    David M. Nathan New England Journal of Medicine
  2. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview (2013)
    David M. Nathan Diabetes Care
  3. Translating the A1C Assay Into Estimated Average Glucose Values (2008)
    David M. Nathan, J.C. Kuenen et al. Diabetes Care
  4. Body Mass Index, Metabolic Syndrome, and Risk of Type 2 Diabetes or Cardiovascular Disease (2006)
    James B. Meigs, Peter W.F. Wilson et al. The Journal of Clinical Endocrinology & Metabolism
  5. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2011)
    David B. Sacks, Mark A. Arnold et al. Clinical Chemistry
  6. The Clinical Information Value of the Glycosylated Hemoglobin Assay (1984)
    David M. Nathan, Daniel E. Singer et al. New England Journal of Medicine
  7. Outpatient Glycemic Control with a Bionic Pancreas in Type 1 Diabetes (2014)
    Steven J. Russell, Firas H. El-Khatib et al. New England Journal of Medicine
  8. Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality (2015)
    Trevor J. Orchard, David M. Nathan et al. JAMA
  9. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023)
    David B. Sacks, Mark A. Arnold et al. Diabetes Care

Immediate Impact

1 by Nobel laureates 84 standout
Sub-graph 1 of 18

Citing Papers

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
2020 Standout
Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association
2019 Standout
16 intermediate papers

Works of David M. Nathan being referenced

Levels of Oxidized LDL and Advanced Glycation End Products–Modified LDL in Circulating Immune Complexes Are Strongly Associated With Increased Levels of Carotid Intima-Media Thickness and Its Progression in Type 1 Diabetes
2010
Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes
2005 Standout
and 10 more

Author Peers

Author Last Decade Papers Cites
David M. Nathan 11908 4031 4157 123 16.4k
Robert E. Ratner 10658 1845 5010 156 16.5k
James H. Warram 6289 3674 3449 186 17.0k
Andrzej S. Królewski 5618 3089 3096 188 15.3k
H. Keen 8950 2214 2787 260 16.1k
Janet B. McGill 8767 1871 3347 230 15.6k
Irl B. Hirsch 16927 5378 6371 347 21.9k
Carol Forsblom 4961 2767 2303 273 11.7k
Helen M. Colhoun 8596 1872 7813 273 18.6k
H. A. W. Neil 9999 1131 6313 112 16.9k
Michel Marre 8347 2111 3239 419 16.6k

All Works

Loading papers...

Rankless by CCL
2026